4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-14-002836
CIK 0001373707operating
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:52 PM ET
Size
5.5 KB
Accession
0001209191-14-002836
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Award
Employee Stock Option (right to buy)
2014-01-08+50,000→ 50,000 totalExercise: $14.99Exp: 2024-01-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Vests as to 6.25% of the shares on 4/8/2014 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/8/2018.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:52 PM ET
- Size
- 5.5 KB